These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. Lepor NE. Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621 [Abstract] [Full Text] [Related]
23. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful? Curvers J, van de Kerkhof D, Stroobants AK, van den Dool EJ, Scharnhorst V. Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710 [Abstract] [Full Text] [Related]
24. Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study. Maegdefessel L, Buerke M, Schubert S, Reindl I, Michel T, Hauroeder B, Carter JM, Peetz D, Werdan K, Schlitt A. Thromb Haemost; 2008 Oct; 100(4):693-8. PubMed ID: 18841294 [Abstract] [Full Text] [Related]
25. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing. Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT. Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620 [Abstract] [Full Text] [Related]